Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today! The post A Snapshot of Five Contenders to Combat Infectious Diseases in the Post-Pandemic Landscape appeared first on MedCity News.
Chiesi Global Rare Diseases is committing up to $115 million to begin a collaboration on Arbor Biotechnologies’ in vivo gene-editing therapy for primary hyperoxaluria type 1, an inherited liver disorder. It’s the rare disease company’s first foray into genetic medicines. The post Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup…
Preeti Bhargava is CTO of Arintra. She is the living embodiment of my crack that the smartest people in the world spent the 2010s convincing people to click on ads and now spend their time figuring out how to bill payers more for providers doing the same work. Arintra is in the RCM business. It…
Last year in Massachusetts, after finding lumps in her breast, Jessica Chen went to Lowell General Hospital-Saints Campus, part of Tufts Medicine, for a mammogram and sonogram. Before the screenings, she asked the hospital for the estimated patient responsibility for the bill using her insurance, Tufts Health Plan. Her portion, she was told, would be…
States are facing constrained budgets, putting pressure on HIV programs, including the Ryan White HIV/AIDS Program. This Policy Watch explores how state Ryan White AIDS Drug Assistance Programs (ADAPs) are responding to these budget pressures, including by restricting eligibility and reducing the scope of services offered, actions that could led to negative health outcomes for…
This brief provides an overview of the TPS program, recent changes to TPS designations announced by the Trump administration, and potential implications of loss of TPS for individuals on health and health care.
A new KFF survey of state Medicaid officials and focus groups in eight states captures the different choices states are making about how to implement Medicaid work requirements, with seven states planning for a more restrictive approach to verifying work or exemption status or to implement work requirements early. These implementation plans are taking shape…
Julie Rovner, KFF Health News’ chief Washington correspondent and host of the What the Health? podcast, recently spoke with Sen. Tammy Baldwin (D-Wis.) about the ongoing fight between President Donald Trump and Congress over control of federal spending. Baldwin, who is a member of the Senate Appropriations Committee and the Senate Health, Education, Labor and…
This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources. The post How Wearables Are Changing the Way We Monitor Cancer Treatment appeared…
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing…